Effect of Ranolazine in Heart Failure Patients with Preserved Ejection Fraction
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2019
At a glance
- Drugs Ranolazine (Primary)
- Indications Heart failure
- Focus Biomarker; Therapeutic Use
- Acronyms ERIPE
- Sponsors Menarini
- 05 Apr 2014 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 27 Oct 2012 Planned End Date changed from 18 Dec 2013 to 23 Apr 2014 as reported by European Clinical Trials Database.
- 17 Aug 2012 New trial record